Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
Based on cases reported to the CDC, this study reports an acceleration in case detection, with a dramatic increase in 2021. From 2019 to 2021, 17 states identified their first case of C auris; however, resistance to echinocandins increased threefold in 2021 compared to the previous two years. And because screening is not conducted uniformly across the United States, the true burden of C auris cases is likely higher than reported.
Allergy & Immunology April 5th 2023
Healthcare IT News
The convenience and comfort telehealth delivers for managing nonurgent and routine care for mental health, chronic disease, or pain is too good to revert back to always in-person appointments. And telehealth is changing the way providers compete — every system is now in direct competition with an expanded list of players. It’s also changing the way consumers select providers. For example, they are moving their care to those that can provide their entire health history online.
All Specialties March 29th 2023
Twelve-hundred (1,200) patients admitted for 48 hours or more for COVID were randomized to 2.5mg of apixaban or placebo twice daily for 30 days. The incidence of death or thromboembolism was low and similar in the two arms of this study. The study was terminated early and the authors say the results are imprecise.
Emergency Medicine March 29th 2023
ACP Internist
The CDC now calls for screening of all adults aged 18 years or older at least once during their lifetimes. And vaccination should be offered to all who have not previously been vaccinated, regardless of serologic testing results. The CDC is now also recommending screening during every pregnancy, preferably in the first trimester, regardless of a patient’s vaccination status or history of testing.
Family Medicine/General Practice March 23rd 2023
Practical Pain Management
Pandemic-era telemedicine exceptions that currently allow telehealth prescription of Schedule II narcotics and stimulants without an initial in-person evaluation are to be ended on May 11.
Anesthesiology March 23rd 2023
In a review of hospitalization records in Hong Kong, Feb-July 2022, adults hospitalized for COVID and given molnupiravir or nirmatrelvir–ritonavir showed lower all-cause mortality, regardless of vaccination status. However, there was no significant reduction in ICU admission or the need for mechanical ventilation.